Intrathecal Drug Delivery for Pain and Spasticity��?- a volume in the new Interventional and Neuromodulatory Techniques for Pain Management series - presents state-of-the-art guidance on the full range of intrathecal drug delivery techniques performed today. Asokumar Buvanendran, MD and Sudhir Diwan, M.D., M.S offer expert advice on a variety of procedures to treat chronic non-malignant pain, cancer pain, and spasticity. Comprehensive, evidence-based coverage on selecting and performing these techniques - as well as weighing relative risks and complications - helps you ensure optimum outcomes. With access to the fully searchable text at www.expertconsult.com, you'll have the detailed visual assistance you need right at your fingertips.
Understand the rationale and scientific evidence behind intrathecal drug delivery techniques and master their execution.
Optimize outcomes, reduce complications, and minimize risks by adhering to current, evidence-based practice guidelines.
Apply the newest techniques in intrathecal pump placement, cancer pain management, use of baclofen pumps, and compounding drugs.
Quickly find the information you need in a user-friendly format with strictly templated chapters supplemented with illustrative line drawings, images, and treatment algorithms.
Access the fully searchable contents online at expertconsult.com.
Series USP: Improve patient safety and minimize risks with evidence-based, step-by-step guidance for interventional and neuromodulatory techniques
SECTION I: General Considerations Chapter 1: Basic Science of Spinal Receptors Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems Chapter 4: Principles of Patient Management for Intrathecal Analgesia Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain Chapter 6: Patient Preparation Chapter 7: Psychological Considerations in IDD Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing SECTION II: Implant Devices Chapter 9: Methods of Trials for Consideration of ITDDS Chapter 10: Techniques of Implant Placement for Intrathecal Pumps Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery Chapter 12: SynchroMed EL vs SynchroMed II Chapter 13: Minimizing the Risks of Intrathecal Therapy Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems SECTION III: Evidence-based practice Chapter 15: Management of ITDDS in Patients with Co-Morbidities Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems Chapter 19: Intrathecal Therapy for Malignant Pain SECTION IV: ITDDs for spasticity Chapter 20: Intrathecal Baclofen Trialing Chapter 21: Baclofen Pump Management SECTION V: Future of ITDDs Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices) Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy Chapter 24: Perioperative Management of Patients with ITDDS